Structural analysis of protein Z gene variants in patients with foetal losses

Summary

The role of protein Z (PZ) in the etiology of human disorders is unclear. A number of PZ gene variants, sporadic or polymorphic and found exclusively in the serine protease domain, have been observed. Crystal structures of PZ in complex with the PZ-dependent inhibitor (PZI) have been recently obtained. The aim of this study was a structural investigation of the serine protease PZ domain, aiming at finding common traits across disease-linked mutations. We performed 10–20 ns molecular dynamics for each of the observed PZ mutants to investigate their structure in aqueous solution. Simulation data were processed by novel tools to analyse the residue-by-residue backbone flexibility. Results showed that sporadic mutations are associated with anomalous flexibility of residues belonging to specific regions. Among them, the most important is a loop region which is in contact with the longest helix of PZI. Other regions have been identified, which hold anomalous flexibility associated with potentially protective gene variants. In conclusion, a possible interpretation of effects associated with observed gene variants is provided. The exploration of PZ/PZI interactions seems essential in explaining these effects.

Keywords

Protein Z - mutants - molecular dynamics - flexibility analysis

• References

• 1 Han X, Huang ZF, Fiehler R. et al. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11073-11078.
• 2 Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-9255.
• 3 Huang X, Swanson R, Broze GJ Jr. et al. Kinetic characterization of the protein Z-dependent protease inhibitor (ZPI) reaction with blood coagulation factor Xa. J Biol Chem 2008; 283: 29770-29783.
• 4 Wei Z, Yan YY, Carrell RW. et al. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X. Blood 2009; 114: 3662-3667.
• 5 Huang X, Dementiev A, Olson ST. et al. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa. J Biol Chem 2010; 285: 20399-20409.
• 6 Santacroce R, Sarno M, Cappucci F. et al. Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost 2006; 04: 2417-2422.
• 7 Pardos-Gea J, Ordi-Ros J, Serrano S. et al. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res 2008; 121: 727-734.
• 8 Grandone E, Favuzzi G, De Stefano V. et al. Protein Z g-42a variant and the risk of pregnancy-related venus thromboembolism in a cohort of italian patients. Thromb Res 2009; 123: 848-859.
• 9 Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G. et al. Low-molecular-weight heparin versus low-dose aspirin in women with one foetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-3699.
• 10 Santacroce R, Cappucci F, Di Perna P. et al. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004; 02: 1197-1199.
• 11 Grandone E, Colaizzo D, Cappucci F. et al. An unreported mutation within protein Z gene is associated with very low protein levels in women with foetal loss. Fert Steril 2008; 90: 864-865.
• 12 Villani M, Tiscia GL, Margaglione M. et al. Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias. J Thromb Haemost 2012; 10: 223-228.
• 13 Grandone E, Colaizzo D, Cappucci F. et al. Protein Z levels and unexplained foetal losses. Fertil. Steril 2004; 82: 982-983.
• 14 Hedstrom L. Serine Protease Mechanism and Specificity. Chem Rev 2002; 102: 4501-4523.
• 15 Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997; 18: 2714-2723.
• 16 Phillips JC, Braun R, Wang W. et al. Scalable molecular dynamics with NAMD. J Comp Chem 2005; 26: 1781-1802.
• 17 Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
• 18 Rossetti G, Cong X, Caliandro R. et al. Common structural traits across disease-linked variants of the human prion protein and their implications for familial prion diseases. J Mol Biol 2011; 411: 700-712.
• 19 Caliandro R, Rossetti G, Carloni P. Local Fluctuations and Conformational Transitions in Proteins. J Chem Theory Comput 2012; 08: 4775-4785.
• 20 Ndonwi M, Lu L, Phillips M. et al. Functional analysis of protein Z (Arg255His) and protein Z-dependent protease inhibitor (Lys25Arg and Ser40Gly) polymorphism. Br J Haematol 2008; 143: 294-303.
• 21 Kemkes-Matthes B, Matthes KJ, Souri M. et al. R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation. Br J Haematol 2004; 128: 248-252.
• 22 Lee CJ, Chandrasekaran V, Duke RE. et al. A proposed structural model of human protein Z. J Thromb Haemost 2007; 05: 1558-1561.
• 23 Di Ventura B, Lemerle C, Michalodimitrakis K. et al. From in vivo to in silico biology and back. Nature 2006; 443: 527-533.